Requests similar to 'Funding of MHRA'

Funding
Response by Medicines and Healthcare Products Regulatory Agency to Janice Worsfold on .

Awaiting classification

FOI 22/907   Dear Ms Janice Worsfold,   Thank you for your email.   The majority of our income comes from the pharmaceutical industry, thro...
Delta Variant Testing
Response by Medicines and Healthcare Products Regulatory Agency to Ann McNeil on .

Information not held

Thank you for your email.  This auto-response is to inform you that your email has been received and will be reviewed by our Customer Service Team. W...
Adverse reactions to Covid 19 vaccinations
Response by Medicines and Healthcare Products Regulatory Agency to Anne Nightingale on .

Long overdue

Reference 80442 Dear Ms Anne Nightingale Thank you for your email dated 13/01/2022. This is just to inform you that we will respond as soon as possib...
IBI Corr oct dec
Response by Medicines and Healthcare Products Regulatory Agency to JJ Evans on .

Successful

Thank you for your email.  This auto-response is to inform you that your email has been received and will be reviewed by our Customer Service Team sh...
COVID-19 Adverse Reaction procedures, policies and templates
Response by Medicines and Healthcare Products Regulatory Agency to D Jackson on .

Partially successful

Our Reference: CEC 112280 Dear Mr Jackson, Thank you for your email. We have redirected your query to the relevant team for further input. Should y...
Can PCR TEST recognize if a virus is alive or dead?
Response by Medicines and Healthcare Products Regulatory Agency to Katon bouzalakos on .

Long overdue

Our Reference: CEC 146338 Dear Katon Bouzalakos, Thank you for your email. We have redirected your query to the relevant team for further input. Sh...
Black inverted triangle mark
Response by Medicines and Healthcare Products Regulatory Agency to Martin Brighty on .

Successful

Our Reference: CEC 118151 Dear Mr Martin Brightly, Thank you for your email. We checked our records and do not appear to have a request sent to us o...
Lipid-related impurity issues for BNT162b2
Response by Medicines and Healthcare Products Regulatory Agency to Jonathan Weissman on .

Awaiting classification

Dear Mr Weissman, According to our records we have responded to you on the other requests, we will send you copies of those responses. We will also s...
Data Storage and IT Infrastructure
Response by Medicines and Healthcare Products Regulatory Agency to Kirsty Watt on .

Awaiting classification

MHRA reference: FOI2024/00029 Dear Kirsty Watt, Thank you for your information request, which we received on 9 April. We have understood your requ...
CBD information request
Response by Medicines and Healthcare Products Regulatory Agency to Cefyn Jones on .

Information not held

MHRA reference: FOI2024/00023 Dear Cefyn Jones, Thank you for your information request, which we received on 4 April. We have understood your requ...
GMP Inspection report post 24 August 2023
Response by Medicines and Healthcare Products Regulatory Agency to Milosevic on .

Awaiting classification

MHRA reference: FOI2024/00013 Dear S. Milosevic, Thank you for your information request, which we received on 26 March. We have understood your re...
Test data and results for each batch of BNT162b2 independently tested by the NIBSC under Regulation 174A
Response by Medicines and Healthcare Products Regulatory Agency to Dr Lee Proctor on .

Awaiting classification

Thank you for your email.  This auto-response is to inform you that your email has been received and will be reviewed by our Customer Service Team. W...
Guidelines for approved bodies auditing medical device manufacturers
Response by Medicines and Healthcare Products Regulatory Agency to Neville Stebbings on .

Partially successful

MHRA reference: FOI2024/00003 Dear Neville Stebbings, Thank you for your information request, which we received on 21 March. We have understood yo...
Essential safety documents relating to BNT162b2
Response by Medicines and Healthcare Products Regulatory Agency to Matt Cooper on .

Information not held

Thank you for your email.  This auto-response is to inform you that your email has been received and will be reviewed by our Customer Service Team. W...
Recall of Moderna vaccine in Japan
Response by Medicines and Healthcare Products Regulatory Agency to Matt Cooper on .

Partially successful

Thank you for your email.  This auto-response is to inform you that your email has been received and will be reviewed by our Customer Service Team. W...
Isle of Man Yellowcard
Response by Medicines and Healthcare Products Regulatory Agency to Natalie Birchall on .

Successful

MHRA reference: IR2024/00143 Dear Natalie Birchall, Thank you for your request for an internal review of your request FOI2024/00051, which we rece...
Coroners' Prevention of Future Deaths Reports 2013-2024
Response by Medicines and Healthcare Products Regulatory Agency to Georgia Richards on .

Successful

MHRA reference: IR2024/00177 Dear Georgia Richards, Thank you for your request for an internal review of your request FOI2024/00106, which we rece...
Informed consent and data availability
Response by Medicines and Healthcare Products Regulatory Agency to Linda Birr-Pixton on .

Awaiting classification

MHRA reference: IR2024/00156 Dear Linda Birr-Pixton, Thank you for your request for an internal review of your request FOI2024/00074, which we rec...
Guidelines for Approved Bodies on the conduct of reviews of medical device manufacturers' technical files under UK Medical Device Regulations 2020 (as amended).
Response by Medicines and Healthcare Products Regulatory Agency to Neville Stebbings on .

Awaiting internal review

MHRA reference: FOI2024/00016 Dear Neville Stebbings, Thank you for your information request, which we received on 1 April. We have understood you...
Adverse Effects of Covid "Vaccination"
Response by Medicines and Healthcare Products Regulatory Agency to Barbara Jones on .

Partially successful

Thank you for your email.  This auto-response is to inform you that your email has been received and will be reviewed by our Customer Service Team. W...
Definition of "Emergency Use"
Response by Medicines and Healthcare Products Regulatory Agency to Roland Gilmore on .

Refused

Thank you for your email.  This auto-response is to inform you that your email has been received and will be reviewed by our Customer Service Team. W...
Suspected adverse reactions to COVID-19 vaccines
Response by Medicines and Healthcare Products Regulatory Agency to Kenneth MacArthur on .

Refused

Thank you for your email.  This auto-response is to inform you that your email has been received and will be reviewed by our Customer Service Team. W...
Are all covid vaccines containing Genetically Modified Organisms? (GMO)
Response by Medicines and Healthcare Products Regulatory Agency to Katon bouzalakos on .

Partially successful

MHRA reference: FOI2024/00055 Dear Katon bouzalakos, Thank you for your information request, which we received on 24 April. We have understood you...
How many circles you set the PCR test for the HIV (AIDS)
Response by Medicines and Healthcare Products Regulatory Agency to Katon bouzalakos on .

Successful

MHRA reference: FOI2024/00144 Dear Katon Bouzalakos, Thank you for your information request, which we received on 24 May. We have understood your...
Manufacturer's package insert for Boostrix-IPV
Response by Medicines and Healthcare Products Regulatory Agency to Kristine Bondarenko on .

Awaiting classification

MHRA reference: FOI2024/00541 Dear Kristine Bondarenko, Thank you for your information request, which we received on 12 September. We have underst...